Hypoxia enhances the expression of plasminogen activator inhibitor-1 in human lung cancer cells, EBC-1

Tohoku Journal of Experimental Medicine

Volumn 196, Issue 4, 2002, Pages 259-267

  Kimura, Daisuke ^a   Imaizumi, Tadaatsu ^a   Tamo, Wakako ^a   Sakai, Takehiro ^a   Ito, Kazuo ^a   Hatanaka, Ryo ^a   Yoshida, Hidemi ^a   Tsushima, Takao ^a   Satoh, Kei ^a   Fukuda, Ikuo ^a  

^a HIROSAKI UNIVERSITY   (Japan)

Author keywords

Hypoxia; Hypoxia inducible factor 1 ; Lung cancer cell; MG132; Plasminogen activator inhibitor 1

Indexed keywords

BENZYLOXYCARBONYLLEUCYLLEUCYLLEUCINAL; DACTINOMYCIN; HYPOXIA INDUCIBLE FACTOR 1ALPHA; MESSENGER RNA; PLASMINOGEN ACTIVATOR INHIBITOR 1; PROTEASOME; BENZYLOXYCARBONYLLEUCYL LEUCYL LEUCINE ALDEHYDE; BENZYLOXYCARBONYLLEUCYL-LEUCYL-LEUCINE ALDEHYDE; CYSTEINE PROTEINASE INHIBITOR; HIF1A PROTEIN, HUMAN; LEUPEPTIN; TRANSCRIPTION FACTOR;

ARTICLE; CANCER CELL; CANCER CELL CULTURE; COMPLEX FORMATION; CONTROLLED STUDY; DRUG INHIBITION; HUMAN; HUMAN CELL; HYPOXIA; LUNG CANCER; METASTASIS; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN SECRETION; BIOSYNTHESIS; CELL CULTURE; CELL HYPOXIA; DRUG EFFECT; GENE EXPRESSION; GENETICS; IMMUNOHISTOCHEMISTRY; LUNG TUMOR; SQUAMOUS CELL CARCINOMA;

CELL HYPOXIA; CYSTEINE PROTEINASE INHIBITORS; DACTINOMYCIN; GENE EXPRESSION; HUMAN; IMMUNOHISTOCHEMISTRY; LEUPEPTINS; LUNG NEOPLASMS; NEOPLASMS, SQUAMOUS CELL; PLASMINOGEN ACTIVATOR INHIBITOR 1; TRANSCRIPTION FACTORS; TUMOR CELLS, CULTURED; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT;

EID: 0035987585     PISSN: 00408727     EISSN: None     Source Type: Journal    
DOI: 10.1620/tjem.196.259     Document Type: Article

References (32)

1. The unique physiology of solid tumors: Opportunities (and problems) for cancer therapy
2. Is plasminogen activator inhibitor-1 the molecular switch that governs urokinase receptor-mediated cell adhesion and release?
3. Interaction of AP-1-, AP-2-, and Sp1-like proteins with two distinct sites in the upstream regulatory region of the plasminogen activator inhibitor-1 gene mediates the phorbol 12-myristate 13-acetate response
4. The role of proteolytic enzymes in cancer invasion and metastasis
5. Angiotensin II induces plasminogen activator inhibitor-1 and -2 expression in vascular endothelial and smooth muscle cells
6. Quantitative gene expression profiles of human liver-derived cell lines exposed to moderate hypoxia
7. Stimulation of plasminogen activator inhibitor-1 expression in immortalized human trophoblast cells cultured under low levels of oxygen
8. Oxygen- and dioxin-regulated gene expression in mouse hepatoma cells
9. Altered expression of several genes in highly metastatic subpopulations of a human pulmonary adenocarcinoma cell line
10. High levels of urokinase-type plasminogen activator and its inhibitor PAI-1 in cytosolic extracts of breast carcinomas are associated with poor prognosis
11. Lipoprotein(a) modulation of endothelial cell surface fibrinolysis and its potential role in atherosclerosis
12. Analysis of expressions of components in the plasminogen activator system in high- and low-metastatic human lung cancer cells
13. Expression of vascular endothelial growth factor in human monocyte/macrophages stimulated with lipopolysaccharide
14. Induction of the plasminogen activator inhibitor-1 gene expression by mild hypoxia via a hypoxia response element binding the hypoxia-inducible factor-1 in rat hepatocytes
15. Urokinase (uPA) and PAI-1 predict survival in advanced ovarian cancer patients (FIGO) III) after radical surgery and platinum-based chemotherapy
16. Co-expression of urokinase, urokinase receptor and PAI-1 is necessary for optimum invasiveness of cultured lung cancer cells
17. Cancer cells overexpress mRNA of urokinase-type plasminogen activator, its receptor and inhibitors in human non-small- cell lung cancer tissue: Analysis by Northern blotting and in situ hybridization
18. Prognostic impact of urokinase-type plasminogen activator and its inhibitor PAI-1 in completely resected gastric cancer
19. Urokinase and plasminogen activator inhibitor type 1 in pulmonary adenocarcinoma
20. Expression of plasminogen activator inhibitors 1 and 2 in lung cancer and their role in tumor progression
21. HIF-1α is required for solid tumor formation and embryonic vascularization
22. Hypoxia-inducible factor 1alpha (HIF-1alpha) protein is rapidly degraded by the ubiquitin-proteasome system under normoxic conditions. Its stabilization by hypoxia depends on redox-induced changes
23. Regulation of type 1 plasminogen activator inhibitor gene expression in cultured bovine aortic endothelial cells: Induction by transforming growth factor-beta, lipopolysaccharide, and tumor necrosis factor-alpha
24. Cytokine activation of vascular endothelium: Effects on tissue-type plasminogen activator and type 1 plasminogen activator inhibitor
25. Hypoxia-inducible factor 1: Control of oxygen homeostasis in health and disease
26. Hypoxia-inducible factor 1alpha protein expression is controlled by oxygen-regulated ubiquitination that is disrupted by deletions and missense mutations
27. The histological structure of some human lung cancers and the possible implications for radiotherapy
28. Hypoxia induces transcription of the plasminogen activator inhibitor-1 gene through genistein-sensitive tyrosine kinase pathways in vascular endothelial cells
29. Plasmin and plasminogen activator inhibitor type 1 promote cellular motility by regulating the interaction between the urokinase receptor and vitronectin
30. General involvement of hypoxia-inducible factor 1 in transcriptional response to hypoxia
31. Purification and characterization of hypoxia-inducible factor 1
32. Temporal, spatial, and oxygen-regulated expression of hypoxia-inducible factor-1 in the lung